Dexamethasone Sodium Phosphate Injection Shortage
Last Updated: March 31, 2025
Status: Current
Products Affected - Description
-
- Dexamethasone Sodium Phosphate injection, Eugia US, 10 mg/mL, 10 mL vial, 10 count, NDC 55150-0305-10
- Dexamethasone Sodium Phosphate injection, Eugia US, 4 mg/mL, 1 mL vial, 25 count, NDC 55150-0237-01
- Dexamethasone Sodium Phosphate injection, Eugia US, 4 mg/mL, 30 mL vial, 25 count, NDC 55150-0239-30
- Dexamethasone Sodium Phosphate injection, Eugia US, 4 mg/mL, 5 mL vial, 25 count, NDC 55150-0238-05
- Dexamethasone Sodium Phosphate injection, Fresenius Kabi, 10 mg/mL, 1 mL preservative-free single dose vial, 25 count, NDC 63323-0506-01
- Dexamethasone Sodium Phosphate injection, Hikma, 10 mg/mL, 1 mL vial, 25 count, NDC 00641-0367-25
- Dexamethasone Sodium Phosphate injection, Hikma, 4 mg/mL, 5 mL vial, 10 count, NDC 00641-6146-10
Reason for the Shortage
-
- American Regent is not marketing dexamethasone sodium phosphate injection at this time.
- Eugia has dexamethasone injection on shortage due to increased demand.
- Fresenius Kabi has dexamethasone injection on shortage due to increased demand.
- Viatris has dexamethasone injection available.
- Hikma has dexamethasone injection on shortage due to increased demand.
- Somerset Therapeutics has 10 mg/mL 1 mL and 10 mL vials available.
Available Products
-
- Dexamethasone Sodium Phosphate injection, Eugia US, 10 mg/mL, 1 mL preservative-free vial, 25 count, NDC 55150-0304-25
- Dexamethasone Sodium Phosphate injection, Fresenius Kabi, 10 mg/mL, 1 mL prefilled syringe, 24 count, NDC 76045-0109-10
- Dexamethasone Sodium Phosphate injection, Fresenius Kabi, 10 mg/mL, 10 mL multiple dose vial, 10 count, NDC 63323-0516-10
- Dexamethasone Sodium Phosphate injection, Fresenius Kabi, 4 mg/mL, 1 mL prefilled syringe, 24 count, NDC 76045-0106-10
- Dexamethasone Sodium Phosphate injection, Fresenius Kabi, 4 mg/mL, 1 mL single dose vial, 25 count, NDC 63323-0165-01
- Dexamethasone Sodium Phosphate injection, Fresenius Kabi, 4 mg/mL, 30 mL multiple dose vial, 1 count, NDC 63323-0165-30
- Dexamethasone Sodium Phosphate injection, Fresenius Kabi, 4 mg/mL, 5 mL multiple dose vial, 25 count, NDC 63323-0165-05
- Dexamethasone Sodium Phosphate injection, Mylan Institutional (Viatris), 10 mg/mL, 10 mL vial, 10 count, NDC 67457-0420-10
- Dexamethasone Sodium Phosphate injection, Mylan Institutional (Viatris), 4 mg/mL, 1 mL vial, 25 count, NDC 67457-0423-12
- Dexamethasone Sodium Phosphate injection, Mylan Institutional (Viatris), 4 mg/mL, 30 mL vial, 25 count, NDC 67457-0421-30
- Dexamethasone Sodium Phosphate injection, Mylan Institutional (Viatris), 4 mg/mL, 5 mL vial, 25 count, NDC 67457-0422-54
- Dexamethasone Sodium Phosphate injection, Somerset Therapeutics LLC, 10 mg/mL, 1 mL preservative-free vial, 25 count, NDC 70069-0021-25
- Dexamethasone Sodium Phosphate injection, Somerset Therapeutics LLC, 10 mg/mL, 10 mL multiple dose vial, 10 count, NDC 70069-0025-10
Estimated Resupply Dates
-
- Eugia has dexamethasone sodium phosphate 4 mg/mL 1 mL, 5 mL, and 30 mL vials and 10 mg/mL 10 mL vials on back order and the company cannot estimate a release date.
- Hikma has dexamethasone sodium phosphate 10 mg/mL 1 mL vials on allocation. The 4 mg/mL 5 mL vials are on back order and the company estimates a release date of late-April to early-May 2025.
- Fresenius Kabi has dexamethasone sodium phosphate 10 mg/mL 1 mL preservative-free vials on back order and the company estimates a release date of late-April 2025.
Updated
Updated March 31, 2025 by Michelle Wheeler, PharmD, Drug Information Specialist. Created March 18, 2011 by Jane Chandramouli, PharmD, Drug Information Specialist. © 2025, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.